Literature DB >> 11982856

Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites.

Virginia Iniesta1, L Carlos Gómez-Nieto, Isabel Molano, Alicia Mohedano, Jesualdo Carcelén, Cristina Mirón, Carlos Alonso, Inés Corraliza.   

Abstract

Leishmania spp. are intracellular protozoan parasites that invade and replicate within macrophages. In a previous report, we have demonstrated that the growth of intracellular amastigotes could be controlled by inhibition of arginase. This enzyme, induced in host cells by Th2 cytokines, synthesizes L-ornithine which can be used by parasites to generate polyamines and proliferate. In this study, we have designed experiments to better analyse the dependence of parasite proliferation on arginase induction in infected macrophages. Treatment of Leishmania major-infected BALB/c macrophages with interleukin (IL)-4, IL-10 or transforming growth factor-beta, which are all inducers of arginase I in murine macrophages, led to a proportional increase in the number of intracellular amastigotes. Moreover, parasite proliferation and arginase activity levels in macrophages from the susceptible BALB/c mice were significantly higher than those from infected C57BL/6 cells when treated with identical doses of these cytokines, indicating that a strong correlation exist between the permissibility of host cells to L. major infection and the induction of arginase I in macrophages. Specific inhibition of arginase by N(omega)-hydroxy-nor-L-arginine (nor-LOHA) reverted growth, while L-ornithine and putrescine promoted parasite proliferation, indicating that the parasite cell division depends critically on the level of L-ornithine available in the host. Therefore, arginase induction in the context of a Th2 predominant response might be a contributor to susceptibility in leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982856     DOI: 10.1046/j.1365-3024.2002.00444.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  64 in total

1.  Arginase I induction during Leishmania major infection mediates the development of disease.

Authors:  Virginia Iniesta; Jesualdo Carcelén; Isabel Molano; Pablo M V Peixoto; Eloy Redondo; Pilar Parra; Marina Mangas; Isabel Monroy; Maria Luisa Campo; Carlos Gómez Nieto; Inés Corraliza
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 2.  Immunobiology of Inherited Muscular Dystrophies.

Authors:  James G Tidball; Steven S Welc; Michelle Wehling-Henricks
Journal:  Compr Physiol       Date:  2018-09-14       Impact factor: 9.090

3.  Urease produced by Coccidioides posadasii contributes to the virulence of this respiratory pathogen.

Authors:  Fariba Mirbod-Donovan; Ruth Schaller; Chiung-Yu Hung; Jianmin Xue; Utz Reichard; Garry T Cole
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis.

Authors:  Helen M Muleme; Rosa M Reguera; Alicia Berard; Richard Azinwi; Ping Jia; Ifeoma B Okwor; Stephen Beverley; Jude E Uzonna
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

5.  Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion.

Authors:  Zhirong Mou; Helen M Muleme; Dong Liu; Ping Jia; Ifeoma B Okwor; Shiby M Kuriakose; Stephen M Beverley; Jude E Uzonna
Journal:  J Immunol       Date:  2013-03-04       Impact factor: 5.422

6.  Oxidative-nitrosative stress and post-translational protein modifications: implications to lung structure-function relations. Arginase modulates NF-kappaB activity via a nitric oxide-dependent mechanism.

Authors:  Karina Ckless; Albert van der Vliet; Yvonne Janssen-Heininger
Journal:  Am J Respir Cell Mol Biol       Date:  2007-01-11       Impact factor: 6.914

7.  Inhibition profile of Leishmania mexicana arginase reveals differences with human arginase I.

Authors:  Eric Riley; Sigrid C Roberts; Buddy Ullman
Journal:  Int J Parasitol       Date:  2011-01-11       Impact factor: 3.981

8.  Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.

Authors:  Anselmo S Souza; Angela Giudice; Júlia Mb Pereira; Luís H Guimarães; Amelia R de Jesus; Tatiana R de Moura; Mary E Wilson; Edgar M Carvalho; Roque P Almeida
Journal:  BMC Infect Dis       Date:  2010-07-15       Impact factor: 3.090

9.  Aberrant host defense against Leishmania major in the absence of SLPI.

Authors:  Nancy McCartney-Francis; Wenwen Jin; Yasmine Belkaid; George McGrady; Sharon M Wahl
Journal:  J Leukoc Biol       Date:  2014-07-16       Impact factor: 4.962

10.  Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival.

Authors:  Matthew Rogers; Pascale Kropf; Beak-San Choi; Rod Dillon; Maria Podinovskaia; Paul Bates; Ingrid Müller
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.